Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis

BACKGROUND: Patients with rheumatoid arthritis (RA) experience extra-articular manifestations including osteoporosis and muscle wasting, which closely associate with severity of disease. Whilst therapeutic glucocorticoids (GCs) reduce inflammation in RA, their actions on muscle and bone metabolism i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenton, C. G., Webster, J. M., Martin, C. S., Fareed, S., Wehmeyer, C., Mackie, H., Jones, R., Seabright, A. P., Lewis, J. W., Lai, Y. C., Goodyear, C. S., Jones, S. W, Cooper, M. S., Lavery, G. G., Langen, R., Raza, K., Hardy, R. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676537/
https://www.ncbi.nlm.nih.gov/pubmed/31370858
http://dx.doi.org/10.1186/s13075-019-1962-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676537/
https://www.ncbi.nlm.nih.gov/pubmed/31370858
http://dx.doi.org/10.1186/s13075-019-1962-3

Ejemplares similares